MYHEP ALL is a new generation medicine that contains 2 active Generics – Sofosbuvir and Velpatasvir. The Mixture is ideally suited to lead a patient to recover from hepatitis C 1, 2, 3, 4, 5, and 6 of the genotype and chronic of the disease. The medicine retains immunity and liver from the harmful effects of the virus.
WHAT IS MYHEP ALL
MyHep All is a medicine that is a mixture of Sofosbuvir & Velpatasvir. The formula of the drug contains just 2 active substances, which have a harmful effect on the causative agent of the disease. The volume of Sofosbuvir and Velpatasvir is selected in an ideal ratio in order to prevent the replication of the hepatitis C virus in the blood.
MYHEP ALL is an effective antiviral. The drug contains Sofosbuvir and Velpatasvir, which can be bought in the form of tablets. The substances belong to the NS5B polymerase suppressor, which is necessary for hepatitis C virus for growth and development. Inhibiting the polymerase, “MYHEP ALL” suppresses the further spread of the virus in the body. Thanks to the drug, the patient can get rid of hepatitis C 1-6 genotype and its chronic form. In this case, the liver of the patient is damaged to a lesser extent and in 8-12 weeks he comes to a full recovery.
FORM OF ISSUE
The price of MYHEP ALL is indicated for a package containing 28 tablets coated with a film sheath. On the one hand, the tablet is marked with a six-pointed star pattern. The jar in which the tablets are packed is equipped with a screw capsule with the control of the first opening.
INDICATIONS FOR USE
The combination of Sofosbuvir and Velpatasvir is used to treat hepatitis C in its chronic form, as well as all six genotypes. Sometimes MYHEP ALL treatment is combined with ribavirin to achieve a speedy recovery. Cirrhosis of the liver or compensated cirrhosis of the liver is not contraindications for taking the drug.
DOSING AND ADMINISTRATION
The treatment regimen for patients suffering from hepatitis C of all 6 genotypes is the same. MYHEP ALL is taken daily. It is necessary to swallow one tablet. Time of reception should coincide. Food has no effect on the effectiveness of the drug. The term of drug use is chosen by the doctor after a comprehensive examination. If the disease occurs without concomitant cirrhosis of the liver, then it is enough to take Sofosbuvir and Velpatasvir for 12 weeks. If the decompensate cirrhosis of the liver is diagnosed, then ribavirin is added. The period of admission is the same as -12 weeks. The price of Sofosbuvir and Velpatasvir allows you to use the product without restrictions.
Usually MYHEP ALL is well tolerated by patients, and no side effects are observed. However, in some cases, the appearance of unpleasant symptoms – headache, nausea, loss of strength. To minimize them, you must adhere to the treatment regimen and avoid overdose.
CONTRAINDICATIONS FOR USE
The take of MYHEP ALL-28TAB is prohibited in patients under 18 years of age, pregnant, lactating women, and if there is an allergy to the components. If there are contraindications to ribavirin, its use should be discarded.
Store the drug at a temperature from + 15C to + 30C in a place inaccessible to children. Do not expose to moisture or direct sunlight.